Regeneron: Q1 Earnings Snapshot

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Thursday reported first-quarter net income of $722 million.

The Tarrytown, New York-based company said it had profit of $6.27 per share. Earnings, adjusted for non-recurring costs and stock option expense, came to $9.55 per share.

The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $10.20 per share.

The biopharmaceutical company posted revenue of $3.15 billion in the period, also missing Street forecasts. Nine analysts surveyed by Zacks expected $3.19 billion.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on REGN at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up